NICE recommends natalizumab for hard-to-control MS
The National Institute for Health and Care Excellence (NICE) has recommended natalizumab as a treatment option for some people living with hard to control MS in England. NICE decides which medicines are available on the NHS in England, and its guidance often influences decisions across the UK. In new final draft guidance, NICE recommends natalizumab
NICE recommends natalizumab for hard-to-control MS Read More »




